We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Biopharma Credit Plc | LSE:BPCR | London | Ordinary Share | GB00BDGKMY29 | ORD USD0.01 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.002 | -0.23% | 0.876 | 0.874 | 0.878 | 0.878 | 0.874 | 0.878 | 1,243,102 | 16:35:04 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Finance Services | 135.74M | 108.45M | 0.0833 | 10.44 | 1.13B |
TIDMBPCR
RNS Number : 2713A
BioPharma Credit PLC
27 December 2017
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i) -------------------------------------------------- 1. Identity of the issuer or BioPharma Credit PLC the underlying issuer of existing shares to which voting rights are attached: (ii) ---------------------------------------------------------- -------------------------- 2. Reason for the notification (please tick the appropriate box or boxes): -------------------------------------------------------------------------------------- An acquisition or disposal of voting rights -------------------------------------------------------------------------------- ---- An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached -------------------------------------------------------------------------------- ---- An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments -------------------------------------------------------------------------------- ---- An event changing the breakdown of voting rights -------------------------------------------------------------------------------- ---- Other (please Issue of New Shares Yes specify): --------------------------------------------------------- --------------------- ---- 3. Full name of person(s) Inteligo Bank Ltd. subject to the notification obligation: (iii) ---------------------------------------------------------- -------------------------- 4. Full name of shareholder(s) (if different from 3.):(iv) ---------------------------------------------------------- -------------------------- 5. Date of the transaction 18 December 2017 and date on which the threshold is crossed or reached: (v) ---------------------------------------------------------- -------------------------- 6. Date on which issuer 21 December 2017 notified: ---------------------------------------------------------- -------------------------- 7. Threshold(s) that is/are crossed or reached: (vi, vii) 8% ---------------------------------------------------------- -------------------------- 8. Notified details: ---------------------------------------------------------------------------------------------------------------------- A: Voting rights attached to shares (viii, ix) ---------------------------------------------------------------------------------------------------------------------- Class/type Situation previous Resulting situation after the of to the triggering triggering transaction shares transaction if possible using the ISIN CODE ------------- -------------------------------- --------------------------------------------------------------------- Number Number Number Number of % of voting of of of shares voting rights (x) Shares Voting rights Rights ------------- --------------- --------------- ------------- --------------------------- ------------------------- Direct Direct Indirect Direct Indirect (xi) (xii) ------------- ----------- ----------- ------------- ------------- ------------ ------------ ----------- Below Below ORD USD0.01 9% 9% 78,525,801 78,525,801 0 8.59% 0.0% --------------- --------------- ------------- ------------- ------------ ------------ ----------- GB00BDGKMY29 ------------- ----------- ----------- ----------- ----------- ------------ -------- --------- B: Qualifying Financial Instruments ---------------------------------------------------------------------------------------------------------------------- Resulting situation after the triggering transaction ---------------------------------------------------------------------------------------------------------------------- Type of Expiration Exercise/ Number of voting % of voting financial date Conversion rights that rights instrument (xiii) Period (xiv) may be acquired if the instrument is exercised/ converted. ----------------- ------------- ------------------------------ ----------------------------- --------------------- N/A N/A N/A N/A N/A ----------------- ------------- ------------------------------ ----------------------------- --------------------- C: Financial Instruments with similar economic effect to Qualifying Financial Instruments (xv, xvi) ---------------------------------------------------------------------------------------------------------------------- Resulting situation after the triggering transaction ---------------------------------------------------------------------------------------------------------------------- Type of Exercise Expiration Exercise/ Number of voting % of voting financial price date Conversion rights instrument rights (xix, instrument (xvii) period refers to xx) (xviii) --------------- ------------- ------------- --------------- ----------------------------- ----------------------- N/A N/A N/A N/A Nominal Delta --------------- ------------- ------------- --------------- ------------ --------- N/A N/A N/A ------------- ----------- ----------- ----------- ----------------------------- ------------ --------- Total (A+B+C) ---------------------------------------------------------------------------------------------------------------------- Number of voting rights Percentage of voting rights ------------------------------------------------- ------------------------------------------------------------------- 78,525,801 8.59% ------------------------------------------------- ------------------------------------------------------------------- 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: (xxi) --------------------------------------------------------------------------------------- N/A Proxy Voting: --------------------------------------------------------------------------------------- 10. Name of the proxy holder: N/A ------------------------------------------------------- ------------------------------ 11. Number of voting rights proxy N/A holder will cease to hold: ------------------------------------------------------- ------------------------------ 12. Date on which proxy holder will N/A cease to hold voting rights: ------------------------------------------------------- ------------------------------ 13. Additional information: ------------------------------------------------------- ------------------------------ 14. Contact name: Victor Vinatea / Guillermo Villanueva ------------------------------------------------------- ------------------------------ 15. Contact telephone number: +507-366-9602 / +507-366-9670 ------------------------------------------------------- ------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLUUVORBRAUUAA
(END) Dow Jones Newswires
December 27, 2017 02:00 ET (07:00 GMT)
1 Year Biopharma Credit Chart |
1 Month Biopharma Credit Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions